Aprocitentan is an oral dual endothelin receptor antagonist, functioning as an ET-A and ET-B blocker to inhibit vasoconstriction and effectively manage resistant hypertension. This category provides access… Read more





Aprocitentan is an oral dual endothelin receptor antagonist, functioning as an ET-A and ET-B blocker to inhibit vasoconstriction and effectively manage resistant hypertension. This category provides access to high-quality reference standards for this pharmaceutical compound, alongside a curated selection of process-related impurities, potential metabolites, and stable isotope-labelled versions such as Aprocitentan-d4. Analytical laboratories utilize these materials for comprehensive impurity profiling, method development, and rigorous quality control protocols during the manufacturing and stability testing of drug formulations. By employing these traceable reference compounds, researchers can ensure accurate identification and quantification of impurities, facilitating compliance with regulatory requirements for pharmaceutical analysis and method validation. Maintaining access to these specialized derivatives supports the ongoing characterization and safety assessment of this antihypertensive therapeutic throughout its development and production lifecycle.